RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes

dc.contributor.authorRot, Antaldeu
dc.contributor.authorKrieger, Martindeu
dc.contributor.authorBrunner, Thomas
dc.contributor.authorBischoff, Stephandeu
dc.contributor.authorSchall, Thomasdeu
dc.contributor.authorDahinden, Clemensdeu
dc.date.accessioned2011-10-25T06:31:23Zdeu
dc.date.available2011-10-25T06:31:23Zdeu
dc.date.issued1992
dc.description.abstractThe cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.eng
dc.description.versionpublished
dc.identifier.citationFirst publ. in: Journal of Experimental Medicine ; 176 (1992), 6. - pp. 1489-1495deu
dc.identifier.doi10.1084/jem.176.6.1489deu
dc.identifier.ppn352227249deu
dc.identifier.urihttp://kops.uni-konstanz.de/handle/123456789/14340
dc.language.isoengdeu
dc.legacy.dateIssued2011-10-25deu
dc.rightsterms-of-usedeu
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/deu
dc.subject.ddc570deu
dc.titleRANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocyteseng
dc.typeJOURNAL_ARTICLEdeu
dspace.entity.typePublication
kops.citation.bibtex
@article{Rot1992RANTE-14340,
  year={1992},
  doi={10.1084/jem.176.6.1489},
  title={RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes},
  number={6},
  volume={176},
  issn={0022-1007},
  journal={Journal of Experimental Medicine},
  pages={1489--1495},
  author={Rot, Antal and Krieger, Martin and Brunner, Thomas and Bischoff, Stephan and Schall, Thomas and Dahinden, Clemens}
}
kops.citation.iso690ROT, Antal, Martin KRIEGER, Thomas BRUNNER, Stephan BISCHOFF, Thomas SCHALL, Clemens DAHINDEN, 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. In: Journal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489deu
kops.citation.iso690ROT, Antal, Martin KRIEGER, Thomas BRUNNER, Stephan BISCHOFF, Thomas SCHALL, Clemens DAHINDEN, 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. In: Journal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14340">
    <dc:contributor>Brunner, Thomas</dc:contributor>
    <dc:contributor>Bischoff, Stephan</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Dahinden, Clemens</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-25T06:31:23Z</dcterms:available>
    <dc:contributor>Krieger, Martin</dc:contributor>
    <dc:contributor>Dahinden, Clemens</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>1992</dcterms:issued>
    <dcterms:abstract xml:lang="eng">The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.</dcterms:abstract>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-25T06:31:23Z</dc:date>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Krieger, Martin</dc:creator>
    <dc:contributor>Schall, Thomas</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <dc:creator>Brunner, Thomas</dc:creator>
    <dc:creator>Rot, Antal</dc:creator>
    <dc:contributor>Rot, Antal</dc:contributor>
    <dc:creator>Bischoff, Stephan</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14340/2/1992_Rot_%20JEM_1292_176_1489_RANTES.pdf"/>
    <dc:creator>Schall, Thomas</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14340/2/1992_Rot_%20JEM_1292_176_1489_RANTES.pdf"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:title>RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes</dcterms:title>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14340"/>
    <dcterms:bibliographicCitation>First publ. in: Journal of Experimental Medicine ; 176 (1992), 6. - pp. 1489-1495</dcterms:bibliographicCitation>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:language>eng</dc:language>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgreen
kops.flag.knbibliographyfalse
kops.identifier.nbnurn:nbn:de:bsz:352-143407deu
kops.sourcefieldJournal of Experimental Medicine. 1992, <b>176</b>(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489deu
kops.sourcefield.plainJournal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489deu
kops.sourcefield.plainJournal of Experimental Medicine. 1992, 176(6), pp. 1489-1495. ISSN 0022-1007. Available under: doi: 10.1084/jem.176.6.1489eng
kops.submitter.emailregine.winter@uni-konstanz.dedeu
relation.isAuthorOfPublicationf61b843f-0378-4683-b89b-70ad6aec10ea
relation.isAuthorOfPublication.latestForDiscoveryf61b843f-0378-4683-b89b-70ad6aec10ea
source.bibliographicInfo.fromPage1489
source.bibliographicInfo.issue6
source.bibliographicInfo.toPage1495
source.bibliographicInfo.volume176
source.identifier.issn0022-1007
source.periodicalTitleJournal of Experimental Medicine

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
1992_Rot_ JEM_1292_176_1489_RANTES.pdf
Größe:
776.42 KB
Format:
Adobe Portable Document Format
1992_Rot_ JEM_1292_176_1489_RANTES.pdf
1992_Rot_ JEM_1292_176_1489_RANTES.pdfGröße: 776.42 KBDownloads: 426

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
license.txt
Größe:
1.92 KB
Format:
Plain Text
Beschreibung:
license.txt
license.txtGröße: 1.92 KBDownloads: 0